Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Tofacitinib may help regrow hair in alopecia areata patients.

Zebularine improved skin structure but delayed wound healing in diabetic mice.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Baricitinib is more effective than methotrexate for severe alopecia areata.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Retinoids may help treat lupus nephritis and reduce steroid use.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.